RELATIONSHIP BETWEEN DIABETES AND COVID-19 SEVERITY IN PATIENTS TREATED AT SAN VICENTE DE PAUL HOSPITAL, JULY 2020 - MARCH 2021
DOI:
https://doi.org/10.53358/lauinvestiga.v9i1.712Keywords:
SARS-CoV-2, COVID 19, Severity level, Correlation, Diabetes mellitusAbstract
In Ecuador, diabetes has a prevalence of 8.5%. However, as of 2019, with the emergence of a new viral disease, it once again took center stage, since this virus affected certain vulnerable groups in a more serious and lethal way, including diabetics, increasing their hospital stay, ICU admission, need for ventilation and death. In this context, the objective of this research is to correlate diabetes and COVID 19 severity in patients treated at San Vicente de Paul hospital. The methodology is retrospective quantitative, in the period of July 2020 - March 2021, collection of data from patients' clinical history in an Excel database, data processing in SPSS using chi-square tests (Pearson and Fisher) to correlation variables, and use of absolute frequencies. Results: 64% of diabetics developed the severe disease, 48% of non-diabetics had moderate COVID, young adults had moderate COVID (46%), while older adults had severe COVID (48%). People with no pathological history tend to develop moderate (50%) and mild (33%) COVID, while people with two or more pathologies have severe disease (66%). It's concluded that there is a strong association between diabetes with a severe and critical disease of COVID 19, the social characteristics are weakly or not related, while the clinical aspects have a very significant statistical association.
Downloads
References
Lima-Martínez MM, Carrera Boada C, Madera-Silva MD, Marín W, Contreras M. COVID-19 y diabetes mellitus: una relación bidireccional. Clinica E Investigacion En Arteriosclerosis [Internet]. 2021 May 1 [cited 2022 Jan 24];33(3):151. Available from: /pmc/articles/PMC7598432/
Haro A, Palacios E. Caracterización epidemiológica de Covid- 19 en Ecuador. InterAm J Med Health. 2020 Apr 17;3.
Ministerio de Salud Pública. Actualización de casos de coronavirus en Ecuador – Ministerio de Salud Pública [Internet]. 2020 [cited 2022 Jan 24]. Available from: https://www.salud.gob.ec/actualizacion-de-casos-de-coronavirus-en-ecuador/
Torres-Tamayo M, Caracas-Portillo NA, Peña-Aparicio B, Juárez-Rojas JG, Medina-Urrutia AX, del R Martínez-Alvarado M. Infección por coronavirus en pacientes con diabetes. Artículo especial [Internet]. 2020 [cited 2022 Jan 24];31(3):235–46. Available from: www.medigraphic.org.mxwww.medigraphic.com/cms
Inzunza G, López R, Ornelas J, Flores G, Ponce M, Peña A. Hiperglucemia intrahospitalaria durante la COVID-19 en pacientes sin diagnóstico previo de diabetes: reporte de tres casos. 2021 Feb 4 [cited 2022 Jan 23];134–42. Available from: https://www.revistadeendocrinologia.com/files/rme_21_8_3_134-142.pdf
González R, Acosta F, Oliva E, Rodríguez S, Cabeza E. Diabetes, hiperglucemia y evolución de pacientes con la COVID-19. Revista Cubana de Medicina Militar [Internet]. 2021 Feb 9 [cited 2022 Jan 23];50(2). Available from: http://scielo.sld.cu/pdf/mil/v50n2/1561-3046-mil-50-02-e910.pdf
Cotelo J. Hiperglucemia al ingreso hospitalario: predictor de mortalidad por COVID-19, con independencia de la diabetes [Internet]. 2020 [cited 2022 Jan 23]. Available from: https://espanol.medscape.com/verarticulo/5906216
Ruiz M. La hiperglucemia, factor de riesgo fuerte en hospitalizados por COVID-19 no críticos [Internet]. 2020 [cited 2022 Jan 24]. Available from: https://gacetamedica.com/investigacion/la-hiperglucemia-factor-de-riesgo-fuerte-en-hospitalizados-por-covid-19-no-criticos/
Luján D, Guatibonza V, Pérez A, Mendivil C. View of COVID-19 pathophysiology and diabetes mellitus | Revista Endocrino. 2020 [Internet]. [cited 2022 Jan 23]; Available from: http://revistaendocrino.org/index.php/rcedm/article/view/586/767
Camacho L, Zavaleta A, Trigoso D. Hiperglucemia como factor pronóstico de mortalidad en pacientes con SARS-CoV-2. 2020 Nov 16 [cited 2022 Jan 24];150–4. Available from: http://revistamedicinainterna.net/index.php/spmi/article/view/562/634
Bellido V, Pérez A. Consecuencias de la COVID-19 sobre las personas con diabetes. Endocrinología, Diabetes y Nutrición [Internet]. 2020 Jun 1 [cited 2022 Jul 11];67(6):355–6. Available from: https://www.elsevier.es/es-revista-endocrinologia-diabetes-nutricion-13-articulo-consecuencias-covid-19-sobre-personas-con-S253001642030104X
Fernanda Chabla-Inga M, Mesa-Cano IC, Alexis Ramírez-Coronel A, Jaya-Vásquez LC. Diabetes as a risk factor for in-hospital mortality in patients with COVID-19: a systematic review.
Hu L, Chen S, Fu Y, Gao Z, Long H, Ren HW, et al. Risk Factors in COVID-19 Outcomes • cid. Clinical Infectious Diseases ® [Internet]. 2089 [cited 2022 Jun 29];2020(16):2089–98. Available from: https://academic.oup.com/cid/article/71/16/2089/5828282
Hu L, Chen S, Fu Y, Gao Z, Long H, Ren HW, et al. Risk Factors Associated With Clinical Outcomes in 323 Coronavirus Disease 2019 (COVID-19) Hospitalized Patients in Wuhan, China. Clinical Infectious Diseases [Internet]. 2020 Nov 19 [cited 2022 Jul 3];71(16):2089–98. Available from: https://academic.oup.com/cid/article/71/16/2089/5828282
Abdi A, Jalilian M, Sarbarzeh PA, Vlaisavljevic Z. Diabetes and COVID-19: A systematic review on the current evidences. Diabetes Research and Clinical Practice. 2020 Aug 1;166:108347.
Fernández García L, Puentes Gutiérrez AB, García Bascones M. Relación entre obesidad, diabetes e ingreso en UCI en pacientes COVID-19. Medicina Clínica. 2020 Oct 9;155(7):314–5.
Wang L, He W, Yu X, Hu D, Bao M, Liu H, et al. Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up. Journal of Infection. 2020 Jun 1;80(6):639–45.
Wan S, Xiang Y, Fang W, Zheng Y, Li B, Hu Y, et al. Clinical features and treatment of COVID-19 patients in northeast Chongqing. Journal of Medical Virology [Internet]. 2020 Jul 1 [cited 2022 Jul 3];92(7):797–806. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25783
Erener S. Diabetes, infection risk and COVID-19. Molecular Metabolism. 2020 Sep 1;39:101044.
Zhang J jin, Dong X, Cao Y yuan, Yuan Y dong, Yang Y bin, Yan Y qin, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy: European Journal of Allergy and Clinical Immunology. 2020 Jul 1;75(7):1730–41
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Odalys Andrea Terán Tabango, Rodrigo Roberto Alvear Reascos
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The authors retain the copyright and guarantee the journal the right to be the first publication of the work as well as licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License that allows others to share the work with an acknowledgment of the authorship of the work and the initial publication in this magazine. Authors may separately establish additional agreements for the non-exclusive distribution of the version of the work published in the journal (for example, placing it in an institutional repository or publishing it in a book), with an acknowledgment of its initial publication in this journal.
La U Investiga by La U Investiga is licensed under a Creative Commons Reconocimiento-NoComercial-CompartirIgual 4.0 Internacional License.You can find permissions beyond those granted with this license athttp://revistasojs.utn.edu.ec/index.php/lauinvestiga/index
